The worldwide medicated skin care products market was predicted at around USD 105 billion in 2013. It is projected to attain about USD 148 billion by 2020. The market is likely to record a CAGR of around 5 percent from 2014 to 2020. This phase marks the forecast period. Asia Pacific dominated the medicated skin care products market in 2013. It is anticipated to display similar trends during the forecast phase.
Clients are increasingly choosing skin care products in Asia Pacific. This is owing to their growing consciousness towards skin care and rising apprehensions in relation to health. Altering living styles and inclination of clients towards beautiful skin in the primary markets of Japan, China, United States and France are adding further revenue to the medicated skin care products market.
Moreover, augmented pollution levels, global warming and apprehensions with regard to the injurious effects of global warming on skin are increasing the demand for the medicated skin care products market. Product advancements are estimated to positively affect the utilization of skin care products across the globe.
Additionally, big investments from producers for the endorsement of products are also a major factor, driving demand for the medicated skin care products market. Broadening delivery channels are making a positive impact on the medicated skin care products market. The market is fragmented into products and geographies. Body lotions and face creams are the two products.
Asia Pacific, North America, Europe and rest of the world are the four geographies under which the medicated skin care products market is analyzed.
Information Source: Grand View Research